Thu, Oct 23, 2014, 2:23 PM EDT - U.S. Markets close in 1 hr 37 mins

Recent

% | $
Quotes you view appear here for quick access.

Vertex Pharmaceuticals Incorporated Message Board

  • I saw the CEO on CNBC last night, round 5 pm. He was asked what effect the NON Announcement or NON report on his drug would have on the company, since it was supposed to happen in New Orleans this week. *I only caught part of the report* He said it shouldn't hurt and we can not do a PR because it has to be announced in a forum, like a medical confrence. Bottom Line, he expects good things when he gets to talk, you get the same feeling from that? or did you not see it?

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • He said he would wait to announce in the med forum, they have to from what I understand

    • I'm amazed he could keep his mouth shut that long especially after the May 10th announcement. The news then was so good it began to leak so he just caved in.

      Now he can "wait until December".
      Makes me wonder.

    • If you guys are refering to the good news I was reporting, all I heard was him say
      " yes we like reporting at these confrences but, when we get to report people will be happy" He was talking about the drugs but did not say which ones. I think think he was going to report progress but not sure it was a completion for any drug. I hope it is though. BTW the news he was talking about was to be presented in New Orleans last week, pushed back to December this year

    • Accordingly to Boger's presentations, the 3 phase 2 950 trials, the merimbodib trial, the 702 and 680 trials are all due to end either in late '05 or early '06.

      So I still don't see what new trial results Boger could have to be reporting this Fall.

      - MML

    • gladpick,
      I think you are correct about the name meerimepodib? I know it was a protease-like inhibitor, taken in conjunction with interferon and riboviron. They are starting 950 trials this fall at the hospital I am being treated.
      gdubya

    • <<Bottom Line, he expects good things when he gets to talk, you get the same feeling from that? or did you not see it?>>
      -----------------------------
      I did not see it. But he is correct regarding his preference of announcing results in a conference. Even though the main points of a conference presentation are usually announced in a press release before the markets open, the publicity that it would generate among attending scientists as well analysts also has a positive imact on the stock. If he wants to wait it seems to me the news must be good. If the reults are bad or mediocare they usually do not wait to present it in a confernce.

      I think Boger will find another forum before the year end to announce news on merimepodib, the details of the plans for VX-950 phase II study based on FDA and european authorities input, vx-702, and vx-765.

      Lets keep our fingers crossed for goood news.

 
VRTX
109.25+3.08(+2.90%)2:22 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.